Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells
MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720
RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy
Evidence for upregulation of Bim and the splicing factor SRp55 in melanoma cells from patients treated with selective BRAF inhibitors
Are you sure you would like to clear your session, including search history and login status?